Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

Item

http://www.wikidata.org/entity/Q34055947

Q34055947

about

Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies The molecular characterization of von Willebrand disease: good in parts Weibel-Palade bodies: a window to von Willebrand disease.Pharmacological characteristics of solid-phase von Willebrand factor in human platelets Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden.Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases.Exposure of platelet fibrinogen receptors by ADP and epinephrine.Quinine- and quinidine-dependent antiplatelet antibodies. Requirement of factor VIII-related antigen for platelet damage and for in vitro transformation of lymphocytes from patients with drug-induced thrombocytopenia Genetic counselling in haemophilia by discriminant analysis 1975-1980 Editorial: The hemophiloid diseases and factor VIII. Clinical molecular biology Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor 8().Studies on the purification and characterization of human factor 8 The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy.Synthesis of antihemophilic factor antigen by cultured human endothelial cells Mesterolone: thrombosis during treatment, and a study of its prothrombotic effects.Von Willebrand factor and von Willebrand disease.Hypercoagulation in glomerulonephritis.Antibody nature of circulating inhibitor of plasma von Willebrand factor.Historical perspective and future directions in platelet research.The interaction of bovine factor VIII with human platelets Studies on hemophilia A in Sardinia bearing on the problems of multiple allelism, carrier detection, and differential mutation rate in the two sexes.The phenotypic range of hemophilia A carriers.Variations in levels of blood clotting factors IX and X in a population of normal men: possible genetic polymorphisms.Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia.Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.The subunit structure of normal and hemophilic factor VIII Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.Purification and characterization of a highly purified human factor VIII consisting of a single type of polypeptide chain.Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities.

P2860

Q24594413-A0F0ABBD-8EF8-493B-8445-80013B3E967F Q26863636-196A6BF2-D01D-417A-884E-4299A2F84FE7 Q26996413-371F6A81-4D61-40B3-929A-4AB6A3F80EE5 Q27693255-FEA149A8-FE39-4C18-AEBF-50D56F057153 Q28190911-4787309B-2BF5-4B1D-916D-25646646870D Q28263702-01695721-371C-4A5E-8BD0-3DC1EC9344DD Q33355402-C7EBD0AA-6C83-4162-A251-1185489F25E6 Q33366163-CD98FD3A-9654-476A-8EE9-ECF349CBDC6D Q33462122-2B8CE932-9AC3-4FC6-8F3E-FAFB53B77697 Q33465072-4A44BBF1-AEDE-4A60-91E7-6C141F7DB55E Q33473239-2D640261-83D4-4304-A721-30EA6E80C627 Q33481532-FBA2807A-12BD-453E-AB23-2D5399E3E19D Q33669314-9608FDE3-3A2A-4B01-A7A8-6E6B2B244547 Q33823350-50C6779F-0117-46AE-9B73-EE568C279C52 Q34039151-FFC59D45-482E-4343-91D8-9A3D68C1FA6A Q34056001-6C96E3C5-A0AF-4F13-889E-BC5AEF81DB61 Q34073430-94E30C4E-7087-4893-877E-EDAE9BA031E9 Q34469121-9B8ABED2-2FE6-4FF3-80C5-8B273A943784 Q34478766-547BFF37-6478-49BA-8904-672D85F51487 Q34482682-B3211CD2-653E-415B-96CE-A76DBEB95A80 Q34505773-2FA91CA7-C581-4A38-99B4-C70063B586AA Q34512731-BACFCA2E-CE24-49FE-A7A1-B0F2C39F6B9A Q34512963-40515F31-E441-4F30-B52D-8D4A7A6941E8 Q34513117-57AB50E1-973D-40B3-96D9-4BBBA03DB660 Q34517370-56B017AD-494B-4631-A68E-563A93CC05A6 Q34530389-561B6C27-0208-4E1B-90AC-CFE64B088C2F Q34782117-DE7B61EA-6AAA-4930-9185-E7D8B54D3332 Q35092624-22E78989-1288-49B2-8F32-D1663FC8992E Q35185593-E3016E64-C39F-40F2-B6F2-8FC9552AF917 Q35195700-E599BE74-5204-4B3C-88F2-E642AB8D98B7 Q35199665-EB60E3B4-F936-47C0-8DD8-A0C14A94C164 Q35201629-B2F5A973-4C60-467F-BF1F-45138383D5CF Q35569193-2D80F3A0-F98B-4E45-A4B8-F69E010E4784 Q35580662-7FB10EB8-A2E3-416E-8955-A9EDE79878B3 Q35897508-480F132A-DDBB-4E05-857C-E7C385E16746 Q35899296-CE65EFF5-DB42-4653-9C55-E839E168A814 Q35899324-5346D59A-8019-4F74-AB4D-F0DAB1EB88E2 Q36275218-EFF10164-B040-4BF9-BDD2-29DD545B5A60 Q36322639-F951EE74-0CB8-4351-AB88-60E52C3D12FD Q36335006-8DE11946-838D-4384-9F39-1461AF68F4A9

P2860

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

Item

http://www.wikidata.org/entity/Q34055947

description

1971 nî lūn-bûn

@nan

1971 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1971 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1971年の論文

@ja

1971年論文

@yue

1971年論文

@zh-hant

1971年論文

@zh-hk

1971年論文

@zh-mo

1971年論文

@zh-tw

1971年论文

@wuu